DE60142914D1 - N-substituierte benzothiophensulfonamid-derivate - Google Patents

N-substituierte benzothiophensulfonamid-derivate

Info

Publication number
DE60142914D1
DE60142914D1 DE60142914T DE60142914T DE60142914D1 DE 60142914 D1 DE60142914 D1 DE 60142914D1 DE 60142914 T DE60142914 T DE 60142914T DE 60142914 T DE60142914 T DE 60142914T DE 60142914 D1 DE60142914 D1 DE 60142914D1
Authority
DE
Germany
Prior art keywords
agent
substituted benzothiophenesulfonamide
substituted
chymase
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60142914T
Other languages
English (en)
Inventor
Shoji Satoh
Akira Tatsui
Takeshi Hasegawa
Hideki Yamada
Shin-Ichi Kazayama
Takahiro Morita
Hidekazu Masaki
Atsuo Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toa Eiyo Ltd
Original Assignee
Toa Eiyo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toa Eiyo Ltd filed Critical Toa Eiyo Ltd
Application granted granted Critical
Publication of DE60142914D1 publication Critical patent/DE60142914D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE60142914T 2000-09-18 2001-09-17 N-substituierte benzothiophensulfonamid-derivate Expired - Lifetime DE60142914D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000282046 2000-09-18
JP2001122972 2001-04-20
PCT/JP2001/008061 WO2002022595A1 (fr) 2000-09-18 2001-09-17 Derives de benzothiophenesulfonamide substitue en n

Publications (1)

Publication Number Publication Date
DE60142914D1 true DE60142914D1 (de) 2010-10-07

Family

ID=26600125

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60142914T Expired - Lifetime DE60142914D1 (de) 2000-09-18 2001-09-17 N-substituierte benzothiophensulfonamid-derivate

Country Status (8)

Country Link
EP (1) EP1325920B1 (de)
JP (1) JP3847711B2 (de)
CN (1) CN1245400C (de)
AT (1) ATE478857T1 (de)
AU (1) AU2001288053A1 (de)
CA (1) CA2422807C (de)
DE (1) DE60142914D1 (de)
WO (1) WO2002022595A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60333351D1 (de) * 2002-03-15 2010-08-26 Toa Eiyo Ltd N-substituiertes benzothiophensulfonamidderivat
JP2003335670A (ja) * 2002-03-15 2003-11-25 Toa Eiyo Ltd 癒着防止剤
CN1871029A (zh) * 2003-08-22 2006-11-29 帝人制药株式会社 含有类糜蛋白酶抑制剂作为有效成分的药物
CA2674644A1 (en) * 2007-01-10 2008-07-17 F. Hoffmann-La Roche Ag Sulfonamide derivatives as chymase inhibitors
US20090163586A1 (en) * 2007-12-20 2009-06-25 Astrazeneca Ab Bis-(Sulfonylamino) Derivatives in Therapy 205
JP6158092B2 (ja) * 2010-12-16 2017-07-05 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ ケモカイン受容体調節因子としての硫黄誘導体
WO2014159657A1 (en) 2013-03-12 2014-10-02 Allergan, Inc. Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
AR098583A1 (es) 2013-12-02 2016-06-01 Allergan Inc Compuesto de sulfonamida de benzotiofeno, composición farmacéutica que lo comprende y su uso para la preparación de dicha composición
CN111285844B (zh) * 2020-02-24 2022-08-12 河南师范大学 具有生物活性的苯并噻吩取代酰胺类化合物及其合成方法和应用
WO2023194222A1 (en) 2022-04-05 2023-10-12 Socpra Sciences Santé Humaines S.E.C. Inhibitors of chymase for use in the selective resolution of thrombi in thrombotic or thromboembolic disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130355C (zh) * 1995-04-04 2003-12-10 德州生物科技公司 调理内皮肽活性的噻吩基－、呋喃基－、吡咯基－与联苯磺酰胺及其衍生物
DE69622148T2 (de) * 1995-09-28 2002-10-31 Suntory Ltd Osaka Chinazozin derivate und deren verwendung
DZ2376A1 (fr) * 1996-12-19 2002-12-28 Smithkline Beecham Plc Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
GB9801392D0 (en) * 1998-01-22 1998-03-18 Smithkline Beecham Plc Novel compounds
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
JP2000095770A (ja) * 1998-07-22 2000-04-04 Toa Eiyo Ltd Ｎ置換チアゾリジン誘導体及びそれを含有する医薬
KR20010089168A (ko) * 1998-08-21 2001-09-29 도리이 신이치로 퀴나졸린 유도체 및 이의 약제학적 용도
GB9818914D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
GB9818916D0 (en) * 1998-08-28 1998-10-21 Smithkline Beecham Plc Use
JP4491866B2 (ja) * 1999-09-30 2010-06-30 三菱化学株式会社 アシルスルホンアミド誘導体

Also Published As

Publication number Publication date
JP3847711B2 (ja) 2006-11-22
WO2002022595A1 (fr) 2002-03-21
JPWO2002022595A1 (ja) 2004-01-22
CN1245400C (zh) 2006-03-15
CN1458928A (zh) 2003-11-26
AU2001288053A1 (en) 2002-03-26
EP1325920B1 (de) 2010-08-25
ATE478857T1 (de) 2010-09-15
CA2422807C (en) 2009-12-08
EP1325920A4 (de) 2005-02-02
CA2422807A1 (en) 2003-03-18
EP1325920A1 (de) 2003-07-09

Similar Documents

Publication Publication Date Title
NO20071719L (no) Pyridylinhibitorer for "hedgehog"-signalisering
ATE478044T1 (de) Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c
ATE286710T1 (de) Antischuppenmittel
ATE481093T1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
ATE511858T1 (de) 2,4,6-triamino-1,3,5-triazin-derivat
NO20021358D0 (no) Alkylendiamin-substituerte heterocykler
NO20062099L (no) Synergistiske fungicide aktive substanskombinasjoner
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
DE50310516D1 (de) Fredericamycin-derivate
YU21702A (sh) Supstituisani indoli za moduliranje nfkb aktivnosti
WO2006113942A3 (en) Method of inhibiting cathepsin activity
ATE438404T1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
NO20026280D0 (no) Melanokortin reseptor-ligander
NO20063324L (no) 3-cyano-kinolinderivater med antiproliferativ aktivitet
DE60142914D1 (de) N-substituierte benzothiophensulfonamid-derivate
BR0308189A (pt) Derivados de alquilaminopirazol 5-substituìdos como pesticidas
ATE357438T1 (de) 1,2,4-triaminobenzolderivate zur behandlung von erkrankungen des zentralnervensystems
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
WO2004053069A3 (en) PROTECTION OF STEM CELLS FROM CYTOTOXIC AGENTS BY MODULATION OF β-CATENIN SIGNALING PATHWAYS
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
WO2009015369A3 (en) Isophthalamide derivatives inhibiting beta-secretase activity
DE60111620D1 (de) Aktiviertes protein c zur behandlung von pankreatitis
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
ATE420636T1 (de) Hemmer der protonenabhängigen kationenkanäle und deren verwendung in der behandlung von ischemiebedingten erkrankungen